Fund Holdings — Rosalind Advisors, Inc.

Total Portfolio Value
$266.23M
Total Bought
$36.42M
Total Sold
$39.85M
Net Transaction
-$3.43M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
FENNEC PHARMACEUTICALS INC(FENC)2,908,2013,188,001+279,80017,88534,27112.87%+16,386
DELCATH SYSTEMS, INC.(DCTH)3,300,3893,300,389030,62841,55215.61%+10,924
CYBIN INC(HELP)1,531,8141,956,814+425,0007,35312,9354.86%+5,582
XERIS BIOPHARMA HOLDINGS INC3,231,7002,908,981-322,71918,74423,0398.65%+4,295
VERASTEM INC(VSTM)2,138,4753,986,509+1,848,03411,33415,2285.72%+3,895
TALPHERA INC(TLPH)3,353,9165,169,501+1,815,5852,5055,3252.00%+2,820
ABIVAX SA(ABVX)020,869+20,86902,7811.04%+2,781
SAVARA INC(SVRA)3,203,7213,178,121-25,60017,49219,5777.35%+2,085
X4 PHARMACEUTICALS INC(XFOR)3,214,7663,214,766013,27715,0135.64%+1,736
REGENTIS BIOMATERIALS LTD(RGNT)251,510701,685+450,1757682,4770.93%+1,709
NEURAXIS INC(NRXS)286,138508,055+221,9171,6942,9711.12%+1,277
MYOMO INC(MYO)3,847,2723,637,886-209,3862,5993,7831.42%+1,184
SPRUCE BIOSCIENCES INC020,000+20,00001,0800.41%+1,080
EYEPOINT PHARMACEUTICALS INC(EYPT)1,036,737988,230-48,50713,36414,1325.31%+768
PEPGEN INC(PEPG)0350,000+350,00006300.24%+630
OVID THERAPEUTICS INC(OVID)1,107,9941,107,99402,4602,9811.12%+521
KURA ONCOLOGY INC(KURA)100,000100,00008131,0970.41%+284
BIOFRONTERA INC(BFRI)1,163,9621,275,609+111,6479421,2060.45%+264
PROFOUND MEDICAL CORP(PROF)828,118828,11805,3665,5072.07%+141
AQUESTIVE THERAPEUTICS INC250,000250,00001,0381,0400.39%+3
VOR BIOPHARMA INC(VOR)700,000648,600-51,40012,48811,9414.49%-547
POLYPID LTD(PYPD)597,926389,455-208,4712,6191,9780.74%-640
MEDIWOUND LTD(MDWD)749,054749,054012,06711,0114.14%-1,056
ANNEXON INC(ANNX)200,0000-200,0001,1080—-1,108
AVALO THERAPEUTICS INC(AVTX)75,0000-75,0001,1200—-1,120
ONKURE THERAPEUTICS INC(OKUR)443,763150,000-293,7631,8376840.26%-1,153
ATEA PHARMACEUTICALS INC(AVIR)1,171,8551,070,550-101,3056,3054,9781.87%-1,327
BIOCRYST PHARMACEUTICALS INC(BCRX)923,057721,504-201,5538,7887,2152.71%-1,572
LIPOCINE INC(LPCN)221,6160-221,6161,7710—-1,771
DEFINIUM THERAPEUTICS INC(DFTX)125,0000-125,0002,3630—-2,362
CELLDEX THERAPEUTICS INC(CLDX)330,000200,000-130,00010,4687,4422.80%-3,026
INSPIREMD INC(NSPR)3,905,7433,905,74306,3662,7341.03%-3,632
VIRIDIAN THERAPEUTICS INC(VRDN)250,4010-250,4014,8980—-4,898
VAXCYTE INC(PCVX)290,000200,000-90,00016,85211,6264.37%-5,226
CG ONCOLOGY INC(CGON)100,0000-100,0006,7680—-6,768
Page 1 of 1
Rosalind Advisors, Inc. — 13F Holdings — Q2 2026 | TickerTrail